David Einhorn: portfolio of Greenlight Capital

David Einhorn leads Greenlight Capital, which follows a value approach; short sales do not appear in the 13F report.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2024. Go to the latest filing (Q3 2026)

2.2B USDQ1 2024
Total value of stock positions
2.2B USD
Positions
42
Share of the ten largest
73.0%

The ten largest positions Q1 2024

  1. Green Brick Partners Inc 28.9%▼ −8.2%
  2. Brighthouse Finl Inc 7.1%▼ −0.7%
  3. Kyndryl HLDGS Inc 6.6%▲ +3.9%
  4. Consol Energy Inc New 6.3%▼ −22.1%
  5. Alight Inc 5.2%▲ +24.7%
  6. Tenet Healthcare Corp 4.3%
  7. The Odp Corp 4.2%▼ −2.1%
  8. Penn Entertainment Inc 3.8%new
  9. Livanova PLC 3.4%▲ +8.4%
  10. Teck Resources Ltd 3.3%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 8.0B USD).
Choose a quarter (54 filings)

All positions Q1 2024

Positions Q1 2024 per 13F filing, 42 of 42
Symbol Weight Shares Reported value Change Held since
Green Brick Partners Inc 28.9% 10,467,383 630.5M USD −8.2% reduced Q4 2014 38 quarters
Brighthouse Finl Inc 7.1% 3,021,763 155.7M USD −0.7% reduced Q3 2017 27 quarters
Teck Resources Ltd 3.3% 1,552,063 71.1M USD unchanged Q2 2020 16 quarters
SPDR Gold TR 2.3% 246,671 50.7M USD −36.3% reduced Q2 2020 16 quarters
Consol Energy Inc New 6.3% 1,640,750 137.4M USD −22.1% reduced Q4 2020 14 quarters
Danimer Scientific Inc 0.1% 2,734,580 3.0M USD unchanged Q4 2020 14 quarters
The Odp Corp 4.2% 1,710,580 90.7M USD −2.1% reduced Q1 2021 13 quarters
Gopro Inc 0.3% 2,823,100 6.3M USD unchanged Q1 2021 13 quarters
Gain Therapeutics Inc < 0.1% 566,130 2.1M USD −3.8% reduced Q1 2021 13 quarters
Nuvation Bio Inc < 0.1% 34,995 127.4K USD unchanged Q1 2021 13 quarters
Nuvation Bio Inc < 0.1% 100,000 30.3K USD unchanged Q1 2021 13 quarters
Livanova PLC 3.4% 1,332,804 74.6M USD +8.4% increased Q2 2021 12 quarters
Graphic Packaging Hldg Co 2.4% 1,796,130 52.4M USD −29.2% reduced Q2 2021 12 quarters
Katapult Holdings Inc < 0.1% 262,227 5.2K USD unchanged Q2 2021 12 quarters
Kyndryl HLDGS Inc 6.6% 6,605,059 143.7M USD +3.9% increased Q4 2021 10 quarters
Galapagos NV 0.2% 159,828 5.1M USD −1.7% reduced Q4 2021 10 quarters
Weatherford Intl PLC 1.7% 317,477 36.6M USD −30.5% reduced Q1 2022 9 quarters
Tenet Healthcare Corp 4.3% 890,630 93.6M USD – Q4 2022 6 quarters
Coya Therapeutics Inc 0.6% 1,274,026 12.6M USD unchanged Q4 2022 6 quarters
First Ctzns Bancshares Inc N 1.9% 25,160 41.1M USD +1.4% increased Q1 2023 5 quarters
Vaneck ETF Trust 0.2% 11,220 3.8M USD +21.0% increased Q1 2023 5 quarters
First TR Exchange-Traded Fd < 0.1% 70,830 1.9M USD +21.0% increased Q1 2023 5 quarters
Invesco Actvely Mngd Etc Fd < 0.1% 117,360 1.6M USD +21.0% increased Q1 2023 5 quarters
Seadrill 2021 Ltd 1.3% 569,405 28.6M USD +4.7% increased Q2 2023 4 quarters
Net Power Inc 1.0% 1,959,280 22.3M USD −34.5% reduced Q2 2023 4 quarters
Sotera Health Co 0.2% 300,110 3.6M USD −10.9% reduced Q2 2023 4 quarters
Neubase Therapeutics Inc < 0.1% 136,350 61.3K USD unchanged Q2 2023 4 quarters
Dht Holdings Inc 2.1% 4,024,340 46.3M USD +6.5% increased Q3 2023 3 quarters
Talis Biomedical Corp < 0.1% 149,052 1.3M USD unchanged Q3 2023 3 quarters
Alight Inc 5.2% 11,527,930 113.6M USD +24.7% increased Q4 2023 2 quarters
VTRS Viatris 2.5% 4,517,620 53.9M USD +34.6% increased Q4 2023 2 quarters
Aercap Holdings NV 1.3% 319,050 27.7M USD +27.6% increased Q4 2023 2 quarters
Invesco Exchange Traded Fd T 0.8% 182,511 18.5M USD −1.6% reduced Q4 2023 2 quarters
SPDR Ser TR 0.8% 127,557 17.9M USD −1.6% reduced Q4 2023 2 quarters
KVUE Kenvue 0.7% 707,740 15.2M USD +27.6% increased Q4 2023 2 quarters
Teva Pharmaceutical Inds Ltd 0.2% 324,850 4.6M USD +21.0% increased Q4 2023 2 quarters
Penn Entertainment Inc 3.8% 4,554,710 82.9M USD new Q1 2024 1 quarter
HPQ HP Inc. 2.2% 1,615,960 48.8M USD new Q1 2024 1 quarter
Roivant Sciences Ltd 2.0% 4,190,490 44.2M USD new Q1 2024 1 quarter
Liberty Global Ltd 1.6% 2,041,580 34.5M USD new Q1 2024 1 quarter
Vaneck ETF Trust 0.2% 111,390 3.5M USD new Q1 2024 1 quarter
Clarivate PLC < 0.1% 279,560 2.1M USD new Q1 2024 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Health Care 2.5%
  • Technology 2.2%
  • Consumer Staples 0.7%
  • not in our coverage 94.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close